MDCXW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -2865.0%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- -0.91
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Medicus Pharma Ltd. Warrant
Company profileMedicus Pharma Ltd. (MDCXW) is an emerging leader in the pharmaceutical industry dedicated to the development and commercialization of advanced therapies addressing critical healthcare needs. Leveraging a robust pipeline powered by innovative research methodologies and compliance with stringent regulatory standards, the company is strategically positioned to respond to the dynamic landscape of medical demands. Medicus Pharma is committed to enhancing patient outcomes and delivering sustainable long-term value for investors through its pioneering healthcare solutions.
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 300 CONSHOHOCKEN STATE ROAD, WEST CONSHOHOCKEN, PA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer